Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The... see more

NDAQ:TLRY - Post Discussion

Tilray Brands, Inc. > CC Pharma now Tilray Pharma
View:
Post by Ventura2020 on Feb 11, 2024 3:09pm

CC Pharma now Tilray Pharma

Tilray Brands Neumunster facility can now grow any strain (was limited to 3) and also is now unlimited on the 1000kg per annum maximum. 

Tilray operates two state-of-the-art GMP-Certified cannabis cultivation facilities in Europe located in Cantanhede, Portugal, and Neumunster, Germany. The E.U. Campus in Portugal is a multi-faceted production facility that includes the cultivation, extraction, processing, and packaging of medical cannabis. It also serves as a hub supporting Tilray'sclinical research and product development efforts across Europe. In addition, Tilray has established sales and distribution arrangements to supply medical cannabis through major pharmaceutical distribution channels, including CC Pharma, throughout Germany and the E.U., which will serve as a means to allowing patients to access Tilray'sGMP-certified finished medical cannabis.

Comment by momocau on Feb 11, 2024 3:42pm
THANK YOU, QUINLASH, AND VENTURA 2020 for your publication. this informs us very well what TILRAY has in Germany. I believe that ZNABIS had an association with a pharmaceutical company and other contacts in Germany. These contacts should now be in TILRAY.
Comment by Ventura2020 on Feb 11, 2024 4:23pm
During Q2, grew international cannabis net revenue by 55%, and are the market leader in medical cannabis across Europe, with leading shares in Germany and Poland and other countries in which we participate. Similar to the U.S., the growth of our international cannabis business is not dependent on adult-use legalization. We continue to take an active government relations role internationally. And ...more  
Comment by Oldweed on Feb 11, 2024 4:48pm
You can throw in HITI as they have partnered with Sanity Group as another Canadian player from a retail angle, and obviously Cura. Allot of investment money will be flowing in for sure, no doubt many plans are in the works, lets hope Irwin has the time to focus on all that is going on in addition to the craft beer market. https://www.healtheuropa.com/exploring-growth-in-the-european-medical ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities